General Session 4: Curative and Loco-Regional Therapies

Chairs: Kim Olthoff, MD (USA) and Norihiro Kokudo, MD (Japan)

  • O-023 Effects on Survival Prognosis by Peretinoin, an Acyclic Retinoid: Five-Year Follow-up of Phase 2/3 Randomized Placebo-Controlled Trial
    K. Okita, H. Kumada, M. Kudo

  • O-024 Survival Outcomes and Prognostic Factors for Intrahepatic Cholangiocarcinoma after Surgical Management: A Retrospective Single-Center Analysis of 1333 Consecutive Patients
    Y. Wang, W. X. Luo, L. Yuan

  • O-025 A Prospective Randomized Controlled Trial to Compare Pringle Manoeuvre with Hemi-Hepatic Vascular Inflow Occlusion in Liver Resection for Hepatocellular Carcinoma with Cirrhosis
    J. Ni, W. Zhou

  • O-026 A Grading System for Micro-Vascular Invasion in Transplanted Hepatocellular Cancer
    S. Roayaie, N. Lubezky, H. Noburo, P. Tabrizian, E. Silberman, H. M. Ko, A. Harrington, J.Hernandez-Prera, I. Fiel, S. Thung, M. Schwartz

  • O-027 Downstaging Hepatocellular Carcinoma: Equivalent Post-Transplant Outcomes Among Patients Initially Categorized Beyond and Within Milan Criteria
    L. Conteh, S. Geevarghese

  • O-028 Radiofrequency Ablation versus Laser Ablation for the Treatment of Small Hepatocellular Carcinoma in Cirrhosis: A Randomized Controlled Trial
    G. G. Di Costanzo, R. Tortora, G. D’Adamo, L. Addario, A. Galeota Lanza, F. Lampasi, M. De Luca, F. Zanfardino, M. T. Tartaglione, S. Mattera, C. M. Pacella